Login / Signup

CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.

Aurélie de ThonelJohanna K AhlskogKevin DaupinVéronique DubreuilJérémy BertheletCarole ChaputGeoffrey PiresCamille LeonettiRyma AbaneLluís Cordón BarrisIsabelle LerayAnna L AaltoSarah NaceriMarine CordonnierCarène BenasoloMatthieu SanialAgathe DuchateauAnniina VihervaaraMikael C PuustinenFederico MiozzoPatricia FergelotÉlise LebigotAlain VerloesPierre GressensDidier LacombeJessica GobboCarmen GarridoSandy D WesterheideLaurent DavidMichel PetitjeanOlivier TaboureauFernando Rodrigues-LimaSandrine PassemardDélara Sabéran-DjoneidiLaurent NguyenMadeline A LancasterLea SistonenValérie Mezger
Published in: Nature communications (2022)
Patients carrying autosomal dominant mutations in the histone/lysine acetyl transferases CBP or EP300 develop a neurodevelopmental disorder: Rubinstein-Taybi syndrome (RSTS). The biological pathways underlying these neurodevelopmental defects remain elusive. Here, we unravel the contribution of a stress-responsive pathway to RSTS. We characterize the structural and functional interaction between CBP/EP300 and heat-shock factor 2 (HSF2), a tuner of brain cortical development and major player in prenatal stress responses in the neocortex: CBP/EP300 acetylates HSF2, leading to the stabilization of the HSF2 protein. Consequently, RSTS patient-derived primary cells show decreased levels of HSF2 and HSF2-dependent alteration in their repertoire of molecular chaperones and stress response. Moreover, we unravel a CBP/EP300-HSF2-N-cadherin cascade that is also active in neurodevelopmental contexts, and show that its deregulation disturbs neuroepithelial integrity in 2D and 3D organoid models of cerebral development, generated from RSTS patient-derived iPSC cells, providing a molecular reading key for this complex pathology.
Keyphrases